查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1785860

全球血液檢測市場

Blood Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 206 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球血液檢測市場規模將達到 1,431 億美元

全球血液檢測市場規模預計在2024年達到933億美元，預計在2024-2030年的分析期內將以7.4%的複合年成長率成長，到2030年將達到1431億美元。血糖檢測是本報告分析的細分市場之一，預計其複合年成長率將達到7.2%，到分析期結束時規模將達到262億美元。糖化血紅素（A1C）檢測細分市場在分析期間的複合年成長率預計將達到6.8%。

美國市場規模估計為 254 億美元，中國市場預計複合年成長率為 11.4%

美國血液檢測市場規模預計在2024年達到254億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到299億美元，在2024-2030年的分析期間內，複合年成長率為11.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.8%和7.1%。在歐洲，預計德國市場的複合年成長率為4.9%。

全球血液學檢測市場—主要趨勢與促進因素摘要

為什麼血液檢測成為現代醫療保健的重要組成部分？

血液檢測是醫療保健領域最基本的診斷程序之一，能夠提供關鍵訊息，了解患者的整體健康狀況、疾病狀態和治療反應。從常規篩檢到複雜的生物標記分析，血液檢測用於診斷感染疾病、代謝障礙、心血管疾病、癌症和自體免疫疾病。慢性病的增加、預防保健意識的增強以及診斷技術的進步，正在推動醫院、診斷實驗室和照護現場對血液檢測的需求。

COVID-19 疫情進一步凸顯了快速、精準血液檢測的重要性，促使人們增加對診斷基礎設施的投資，並採用 PCR 檢測和血清學檢測等先進技術。此外，個人化醫療和精準診斷擴大了血液檢測在指導標靶治療的作用，尤其是在腫瘤和遺傳疾病領域。隨著醫療保健持續轉向早期疾病檢測和預防保健，對快速、精準、微創血液檢測解決方案的需求預計將大幅增加。

科技進步如何改變血液檢測？

血液檢測技術的關鍵創新提高了準確性、速度和便利性，使患者和醫療保健提供者更容易獲得診斷。該領域最具突破性的進展之一是液態切片技術的開發。液態切片能夠透過血液中的循環腫瘤DNA (ctDNA) 和生物標記檢測癌症和其他疾病。液態切片為傳統組織切片檢查提供了一種非侵入性替代方案，可實現早期癌症檢測、疾病監測和治療反應評估。

血液檢測的另一個突破是照護現場(POC) 和家用血液檢測設備的出現。這些可攜式、方便用戶使用的系統無需完整的實驗室設置即可快速檢測血糖、膽固醇、感染疾病和凝血水平。此外，人工智慧 (AI) 和機器學習 (ML) 正在整合到診斷平台中，以增強測試解讀、改進預測分析並減少診斷錯誤。微流體和實驗室晶片技術的採用也簡化了樣本處理，能夠以最少的樣本量進行快速、自動化的血液分析。這些技術進步不斷發展，透過實現更快、更準確的診斷和更以患者為中心的醫療保健，改變了醫療格局。

哪些市場趨勢將推動血液檢測產業的成長？

對預防性醫療保健和定期體檢的日益重視是推動血液檢測市場發展的最重要趨勢之一。隨著糖尿病、心血管疾病和肝損傷等文明病率不斷上升，越來越多的人選擇定期進行血液檢測，以便及早發現和評估風險。直銷 (DTC) 服務的日益普及也推動了市場的發展，這些服務允許消費者無需醫生轉診即可在線訂購檢測。這些服務允許在家中採集樣本並以數位化方式解讀結果，為注重健康的消費者提供了更大的便利性和可及性。

影響市場的另一個關鍵趨勢是基於基因和生物標記的血液檢測的擴展。隨著精準醫療的日益普及，血液檢測正被用於識別疾病的遺傳易感性、指導標標靶治療以及監測病情進展。此外，遠端醫療和遠端患者監護的興起正在加速連網血液檢測設備的普及，這些設備可與數位健康平台同步，實現即時追蹤和醫生諮詢。全球對感染疾病監測的日益關注，包括抗菌素抗藥性等新興威脅，也推動了對快速、高通量血液檢測解決方案的需求。

影響血液學檢測市場未來發展的關鍵成長動力有哪些？

血液檢測市場的成長受到多種關鍵因素的推動，包括疾病的流行、診斷技術的進步以及醫療保健投資的增加。其中一個主要成長要素是慢性病和感染疾病的發生率不斷上升，這推動了對早期準確診斷的需求。世界各國政府和醫療保健組織都將疾病預防和早期療育介入放在首位，這導致常規血液檢測在人口健康管理中的應用日益普及。

影響市場的另一個關鍵因素是日益轉向分散式和居家式偵測解決方案。隨著消費者對便利性和可近性的需求不斷提升，診斷公司正在投資可攜式、方便用戶使用的血液檢測設備，這些設備無需前往實驗室即可快速獲得結果。此外，數據分析和人工智慧驅動診斷技術的進步正在提高檢測準確性，並實現針對各種疾病的個人化風險評估和預測模型。隨著全球醫療保健格局的不斷發展，市場格局預計將因創新、健康意識的提升以及對更高效、更具成本效益的診斷解決方案的持續追求而擴大。

部分

測試類型（葡萄糖測試、A1C 測試、直接 LDL 測試、血脂檢查、前列腺特異性抗原測試、COVID-19 測試、BUN 測試、維生素 D 測試、甲狀腺刺激素(TSH) 測試、血清尼古丁/可替寧測試、高敏 CRP 測試、睾酮測試、ALT 測試、皮質醇測試、肌酐測試、AST 測試、其他血液測試、睪固酮測試、其他血液測試、研究血液測試、肌酸酐測試）

受訪公司範例

  • Abbott Laboratories
  • ARUP Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories
  • Cepheid
  • Charles River Laboratories
  • Eurofins Scientific
  • Genomic Health
  • Illumina
  • Labcorp（Laboratory Corp of America）
  • Myriad Genetics
  • Natera
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP29650

Global Blood Testing Market to Reach US$143.1 Billion by 2030

The global market for Blood Testing estimated at US$93.3 Billion in the year 2024, is expected to reach US$143.1 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Glucose Testing, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$26.2 Billion by the end of the analysis period. Growth in the A1C Testing segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.4 Billion While China is Forecast to Grow at 11.4% CAGR

The Blood Testing market in the U.S. is estimated at US$25.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$29.9 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Blood Testing Market - Key Trends & Drivers Summarized

Why Is Blood Testing Becoming More Essential in Modern Healthcare?

Blood testing is one of the most fundamental diagnostic procedures in healthcare, providing critical insights into a patient’s overall health, disease status, and treatment response. From routine screenings to complex biomarker analysis, blood tests are used for diagnosing infections, metabolic disorders, cardiovascular diseases, cancers, and autoimmune conditions. The increasing prevalence of chronic diseases, rising awareness of preventive healthcare, and advancements in diagnostic technology have fueled the demand for blood testing in hospitals, diagnostic laboratories, and point-of-care settings.

The COVID-19 pandemic further highlighted the importance of rapid and accurate blood testing, leading to increased investments in diagnostic infrastructure and the adoption of advanced technologies, such as PCR-based and serological tests. Additionally, personalized medicine and precision diagnostics have expanded the role of blood testing in guiding targeted therapies, particularly in oncology and genetic disorders. As healthcare systems continue to shift toward early disease detection and preventive care, the demand for fast, accurate, and minimally invasive blood testing solutions is expected to rise significantly.

How Are Technological Advancements Transforming Blood Testing?

Significant innovations in blood testing technology are enhancing accuracy, speed, and convenience, making diagnostics more accessible to patients and healthcare providers. One of the most transformative advancements in this field is the development of liquid biopsy technology, which enables the detection of cancer and other diseases through circulating tumor DNA (ctDNA) and biomarkers in the blood. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, allowing for early cancer detection, disease monitoring, and treatment response evaluation.

Another breakthrough in blood testing is the emergence of point-of-care (POC) and home-based blood testing devices. These portable and user-friendly systems enable rapid testing for glucose, cholesterol, infectious diseases, and coagulation levels without requiring a full laboratory setup. Additionally, artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic platforms to enhance test interpretation, improve predictive analytics, and reduce diagnostic errors. The adoption of microfluidic and lab-on-a-chip technologies has also streamlined sample processing, enabling rapid and automated blood analysis with minimal sample volumes. As these technological advancements continue to evolve, they are revolutionizing the blood testing landscape, making diagnostics faster, more precise, and increasingly patient-centric.

Which Market Trends Are Driving Growth in the Blood Testing Industry?

The growing emphasis on preventive healthcare and routine screening is one of the most influential trends driving the blood testing market. With a rise in lifestyle-related conditions such as diabetes, cardiovascular diseases, and liver disorders, more individuals are undergoing regular blood tests for early detection and risk assessment. The increasing availability of direct-to-consumer (DTC) blood testing services, where individuals can order tests online without a physician’s referral, is also fueling market expansion. These services offer at-home sample collection and digital result interpretation, providing greater convenience and accessibility for health-conscious consumers.

Another key trend shaping the market is the expansion of genetic and biomarker-based blood tests. As precision medicine gains traction, blood testing is being used to identify genetic predispositions to diseases, guide targeted treatments, and monitor disease progression. Additionally, the rise of telemedicine and remote patient monitoring has accelerated the adoption of connected blood testing devices that sync with digital health platforms, enabling real-time tracking and physician consultations. The growing global focus on infectious disease surveillance, including emerging threats such as antimicrobial resistance, is also driving demand for rapid and high-throughput blood testing solutions.

What Are the Key Growth Drivers Shaping the Future of the Blood Testing Market?

The growth in the blood testing market is driven by several critical factors, including rising disease prevalence, advancements in diagnostic technology, and increasing healthcare investments. One of the primary growth drivers is the rising incidence of chronic and infectious diseases, which has led to an increased need for early and accurate diagnosis. Governments and healthcare organizations worldwide are prioritizing disease prevention and early intervention, leading to greater adoption of routine blood testing for population health management.

Another crucial driver shaping the market is the increasing shift toward decentralized and at-home testing solutions. As consumers demand greater convenience and accessibility, diagnostic companies are investing in portable, user-friendly blood testing devices that provide rapid results without the need for laboratory visits. Additionally, advancements in data analytics and AI-driven diagnostics are enhancing test accuracy, enabling personalized risk assessments and predictive modeling for various diseases. As the global healthcare landscape continues to evolve, the blood testing market is expected to expand, driven by innovation, increasing health awareness, and the continuous pursuit of more efficient, cost-effective diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Blood Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone (TSH) Testing, Serum Nicotine/Cotinine Testing, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • ARUP Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • Cepheid
  • Charles River Laboratories
  • Eurofins Scientific
  • Genomic Health
  • Illumina
  • Labcorp (Laboratory Corp of America)
  • Myriad Genetics
  • Natera
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Blood Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Disease Burden Across Populations Throws the Spotlight on Preventive and Routine Blood Testing
    • Rising Demand for Early Diagnosis and Risk Stratification Propels Growth in Comprehensive Blood Testing Panels
    • Expansion of Point-of-Care Testing (POCT) Ecosystems Drives Decentralized Blood Testing Adoption
    • Technological Advancements in Microfluidics and Lab-on-Chip Devices Expand the Addressable Market for Rapid Testing Solutions
    • AI and Predictive Analytics Integration Strengthens the Business Case for Smart, Data-Driven Blood Diagnostics
    • Shift Toward Personalized and Precision Medicine Accelerates Demand for Biomarker-Based Blood Tests
    • Consumerization of Diagnostics Fuels Growth in At-Home Blood Testing Kits and Services
    • Proliferation of Telehealth Models Drives the Need for Seamless Remote Blood Testing Integration
    • Increased Utilization of Multiplex Testing Platforms Spurs Efficiency and Cost-Effectiveness in Labs
    • Growing Preference for Non-Invasive and Minimal Sample Volume Testing Sustains Demand for Capillary Blood Solutions
    • Public Health Initiatives and Screening Campaigns Generate Widespread Demand Across Demographic Segments
    • Rising Awareness of Lifestyle-Related Disorders Strengthens Market Uptake in Wellness and Preventive Health Sectors
    • Digital Health Integration and EHR Compatibility Propel Adoption of Connected Blood Testing Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for A1C Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for A1C Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for A1C Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Direct LDL Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Direct LDL Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Direct LDL Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lipid Panel Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lipid Panel Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Lipid Panel Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prostate-specific Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prostate-specific Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Prostate-specific Antigen Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for BUN Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for BUN Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for BUN Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Vitamin-D Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Vitamin-D Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Vitamin-D Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thyroid-stimulating Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thyroid-stimulating Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Thyroid-stimulating Hormone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • JAPAN
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • CHINA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • EUROPE
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Blood Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • FRANCE
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • GERMANY
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Blood Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • INDIA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Blood Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Blood Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • AFRICA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030

IV. COMPETITION